We are live on ! Find out more
MH

Mark Hillman Hillman Capital Management

AUM $138M
1-Year Est. Return 8.57%
 

Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.

This Fund
S&P 500
This Quarter Est. Return
+7.11%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
AUM
$263M
AUM Growth
+$34.8M
Cap. Flow
+$18.4M
Cap. Flow %
7.02%
Top 10 Hldgs %
36.83%
Holding
48
New
5
Increased
28
Reduced
11
Closed

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$8.16M
2
T icon
AT&T
T
+$1.88M
3
MRK icon
Merck
MRK
+$1.81M
4
AMZN icon
Amazon
AMZN
+$1.72M
5
CMP icon
Compass Minerals
CMP
+$1.5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.44%
2 Communication Services 14.07%
3 Energy 12.69%
4 Consumer Staples 10.65%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
1
Wells Fargo
WFC
$254B
$10.4M 3.97%
230,258
-337
-0.1% -$15K
AMZN icon
2
Amazon
AMZN
$2.79T
$10.3M 3.91%
59,760
+10,360
+21% +$1.72M
XOM icon
3
ExxonMobil
XOM
$679B
$9.96M 3.79%
157,854
+886
+0.6% +$52.9K
SPG icon
4
Simon Property Group
SPG
$70.6B
$9.89M 3.76%
75,803
+7,340
+11% +$912K
PAA icon
5
Plains All American Pipeline
PAA
$17.4B
$9.78M 3.72%
861,125
+5,417
+0.6% +$55.6K
BIIB icon
6
Biogen
BIIB
$32B
$9.43M 3.59%
27,239
-50
-0.2% -$15.1K
KHC icon
7
Kraft Heinz
KHC
$30.3B
$9.37M 3.56%
229,675
+15,318
+7% +$645K
GSK icon
8
GSK
GSK
$105B
$9.3M 3.54%
186,860
+1,208
+0.7% +$58K
BUD icon
9
AB InBev
BUD
$155B
$9.26M 3.52%
128,521
+720
+0.6% +$52.5K
CVS icon
10
CVS Health
CVS
$119B
$9.09M 3.46%
108,929
+710
+0.7% +$58.1K
T icon
11
AT&T
T
$173B
$8.95M 3.41%
411,809
+82,751
+25% +$1.88M
K
12
DELISTED
Kellanova
K
$8.88M 3.38%
147,085
+2,732
+2% +$166K
MSFT icon
13
Microsoft
MSFT
$3.59T
$8.88M 3.38%
32,769
+885
+3% +$225K
BA icon
14
Boeing
BA
$169B
$8.08M 3.08%
33,736
+205
+0.6% +$49.6K
DD icon
15
DuPont de Nemours
DD
$18.7B
$7.93M 3.02%
81,641
+464
+0.6% +$46.6K
BMY icon
16
Bristol-Myers Squibb
BMY
$137B
$7.89M 3%
118,057
+950
+0.8% +$61.9K
EPD icon
17
Enterprise Products Partners
EPD
$82.1B
$7.88M 3%
326,491
+2,608
+0.8% +$61.7K
CMP icon
18
Compass Minerals
CMP
$1.09B
$7.56M 2.88%
127,613
+22,631
+22% +$1.5M
MRK icon
19
Merck
MRK
$376B
$7.43M 2.83%
95,557
+24,316
+34% +$1.81M
WBD icon
20
Warner Bros
WBD
$71.6B
$7.22M 2.75%
+235,326
New +$8.16M
INTC icon
21
Intel
INTC
$476B
$7.16M 2.72%
127,453
+7,421
+6% +$436K
META icon
22
Meta Platforms (Facebook)
META
$1.4T
$7.13M 2.71%
20,511
-6
-0% -$1.93K
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$4.22T
$7.08M 2.69%
58,000
-2,000
-3% -$234K
PFE icon
24
Pfizer
PFE
$160B
$6.62M 2.52%
169,105
+450
+0.3% +$17.5K
RTX icon
25
RTX Corp
RTX
$283B
$6.26M 2.38%
73,339

Similar funds

Mark Hillman's Q2 2021 Portfolio in Review

As of Q2 2021, Mark Hillman held 48 positions worth $263M, up 15% from $228M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mark Hillman deployed $18.4M of net new capital in Q2 2021, opening 5 new positions and adding to 28 existing holdings. Its largest new stake was Warner Bros: 235,326 shares worth $7.22M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $234K trimmed.

  • Mark Hillman's largest Q2 2021 buy was Warner Bros: 235,326 shares worth $7.22M.
  • Mark Hillman added most to AT&T in Q2 2021, an estimated $1.88M increase.
  • Mark Hillman's biggest Q2 2021 reduction was Alphabet (Google) Class A, cutting an estimated $234K.
  • Mark Hillman's ten largest holdings make up 37% of its $263M portfolio in Q2 2021.
  • Mark Hillman opened 5 new positions and closed 0 in Q2 2021.
  • Mark Hillman's portfolio value rose 15% quarter-over-quarter to $263M.

Based on Hillman Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.